Methotrexate as an alternative therapy for chronic calcium pyrophosphate deposition disease: an exploratory analysis.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Arthritis & Rheumatism

• Publication date

  2007-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ART.22389PMID 17265505
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inorganic pyrophosphate (PPI) in pathologic calcification of articular cartilage.

  2005cited by this paper
• Genetic studies of chondrocalcinosis

  2005cited by this paper
• Inflammation and tissue damage in crystal deposition diseases

  2005cited by this paper
• Low-Dose Methotrexate: A Mainstay in the Treatment of Rheumatoid Arthritis

  2005cited by this paper
• Biologic effects of calcium-containing crystals

  2005cited by this paper
• Long term safety of methotrexate in routine clinical care: discontinuation is unusual and rarely the result of laboratory abnormalities

  2004cited by this paper
• Adenosine: an endogenous regulator of innate immunity.

  2004cited by this paper
• A cost effectiveness analysis of treatment options for methotrexate-naive rheumatoid arthritis.

  2002cited by this paper
• Safety of low dose methotrexate in elderly patients with rheumatoid arthritis

  2000cited by this paper
• Calcium crystal effects on the cells of the joint: implications for pathogenesis of disease.

  2000cited by this paper
• Molecular and cellular effects of methotrexate.

  1999cited by this paper
• Longterm prospective study of methotrexate in rheumatoid arthritis: conclusion after 132 months of therapy.

  1998cited by this paper
• The effects of drug therapy on radiographic progression of rheumatoid arthritis. Results of a 36-week randomized trial comparing methotrexate and auranofin.

  1993cited by this paper
• Colchicine prophylaxis in pseudogout.

  1986cited by this paper
• Calcium pyrophosphate dihydrate crystal deposition disease: nomenclature and diagnostic criteria.

  1977cited by this paper

• Calcium Pyrophosphate Deposition Disease is Independently Associated With a Durotomy During an Open Lumbar Decompression: Results of a Propensity-Matched Cohort Analysis

  2025cites this paper
• Treatment of calcium pyrophosphate crystal deposition disease: a mini-review

  2025cites this paper
• Artropatías por depósitos de pirofosfato cálcico y condrocalcinosis

  2025cites this paper
• A Narrative Review of Chondrocalcinosis: Clinical Presentation, Diagnosis, and Therapies

  2024cites this paper
• CPPD—differential diagnostics and differential therapeutic challenges

  2024cites this paper
• Calcium pyrophosphate deposition disease: historical overview and potential gaps

  2024cites this paper
• Recent advances in the therapeutic management of calcium pyrophosphate deposition disease

  2024influential citation
• Rhumatisme à dépôts de pyrophosphate de calcium et chondrocalcinose

  2024cites this paper
• Retention, safety and efficacy of off-label conventional treatments and biologics for chronic calcium pyrophosphate crystal inflammatory arthritis.

  2023cites this paper
• Histone Deacetylase Inhibitors Downregulate Calcium Pyrophosphate Crystal Formation in Human Articular Chondrocytes

  2022cites this paper
• A Patient with Symmetrical Polyarthritis. The Value of Conventional Radiography for a Correct Diagnosis

  2022cites this paper
• An Unusual Pathologic Ulna Fracture Induced by Intraosseous Tumoral Calcium Pyrophosphate Dihydrate Crystal Deposition Disease

  2022cites this paper
• Lumbar Extradural Pseudogout Mass Manifesting as Radiculopathy: A Case Report

  2021cites this paper
• Kristallarthropathien - nicht immer ist es eine Gicht!

  2020cites this paper
• Management of calcium pyrophosphate crystal deposition disease: A systematic review.

  2020cites this paper
• Outcome domains reported in calcium pyrophosphate deposition studies: A scoping review by the OMERACT CPPD working group.

  2020cites this paper
• Kalziumkristalle im Gelenk

  2020cites this paper
• Updated Treatment for Calcium Pyrophosphate Deposition Disease: An Insight

  2019cites this paper
• Cartilage diseases.

  2018cites this paper
• Calcium crystal deposition diseases — beyond gout

  2018cites this paper
• Review: Unmet Needs and the Path Forward in Joint Disease Associated With Calcium Pyrophosphate Crystal Deposition

  2018cites this paper
• Therapy for CPPD: Options and Evidence

  2018cites this paper
• Chapter 96 – Calcium Crystal Disease: Calcium Pyrophosphate Dihydrate and Basic Calcium Phosphate

  2017cites this paper
• Magnesium disorders can cause calcium pyrophosphate deposition disease: A case report and literature review.

  2017cites this paper
• Female hormonal factors and the development of anti-citrullinated protein antibodies in women at risk of rheumatoid arthritis

  2017cites this paper
• Gitelman syndrome: consensus and guidance from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

  2017cites this paper
• Update on calcium pyrophosphate deposition.

  2016cites this paper
• Calcium-Containing Crystal-Associated Arthropathies in the Elderly Population

  2016cites this paper
• Calcium Pyrophosphate Deposition Disease.

  2016cites this paper
• Current advances in therapies for calcium pyrophosphate crystal arthritis

  2016cites this paper
• Gout and calcium pyrophosphate dihydrate deposition disease

  2016cites this paper
• Chondrokalzinosen und sonstige Kristallarthropathien

  2016cites this paper
• Seminarios de la Fundación Española de Reumatología

  2016cites this paper
• A prospective evaluation of ultrasound as a diagnostic tool in acute microcrystalline arthritis

  2015cites this paper
• 190 – Calcium pyrophosphate crystal–associated arthropathy

  2015cites this paper
• Methotrexate: should it still be considered for chronic calcium pyrophosphate crystal disease?

  2015cites this paper
• Pain reduction with oral methotrexate in knee osteoarthritis, a pragmatic phase iii trial of treatment effectiveness (PROMOTE): study protocol for a randomized controlled trial

  2015influential citation
• Treatment of Nongout Joint Deposition Diseases: An Update

  2014cites this paper
• AMP-activated protein kinase suppresses urate crystal-induced inflammation and transduces colchicine effects in macrophages

  2014cites this paper
• Methotrexate in chronic-recurrent calcium pyrophosphate deposition disease: no significant effect in a randomized crossover trial

  2014cites this paper
• Nonpharmacologic and pharmacologic management of CPP crystal arthritis and BCP arthropathy and periarticular syndromes.

  2014cites this paper
• The acutely swollen knee. Part 1: Management of atraumatic pathology.

  2014cites this paper
• 96 – Calcium Crystal Disease: Calcium Pyrophosphate Dihydrate and Basic Calcium Phosphate

  2013cites this paper
• [Gitelman syndrome: a crucial role of laboratory medicine for the diagnosis].

  2013cites this paper
• Chapitre 2 – Affections microcristallines

  2013cites this paper
• Methotrexate Is an Option for Patients With Refractory Calcium Pyrophosphate Crystal Arthritis

  2012influential citation
• Calcium pyrophosphate deposition disease: clinical manifestations.

  2012cites this paper
• Protective effect of methotrexate in patients with rheumatoid arthritis and cardiovascular comorbidity

  2012cites this paper
• Efficacité de l’anakinra dans la chondrocalcinose articulaire : rapport de trois cas

  2012cites this paper
• EULAR Textbook on Rheumatic Diseases

  2012cites this paper
• Arthritis, Muscle, Adipose Tissue, and Bone Diseases of Nonhuman Primates

  2012cites this paper
• Calcium Pyrophosphate Dihydrate Crystal Deposition: Epidemiology, Clinical Features, Diagnosis, and Treatment

  2012cites this paper
• Efficacy of anakinra in articular chondrocalcinosis: report of three cases.

  2012cites this paper
• Treatment and management of pseudogout: insights for the clinician

  2012cites this paper
• Genetics and epidemiology of ectopic calcification.

  2011cites this paper
• EULAR recommendations for calcium pyrophosphate deposition. Part II: Management

  2011cites this paper
• Ankylosing spondylitis, late osteoarthritis, vascular calcification, chondrocalcinosis and pseudo gout: toward a possible drug therapy.

  2011cites this paper
• Pathophysiology of articular chondrocalcinosis—role of ANKH

  2011cites this paper
• Calcium pyrophosphate crystal deposition

  2011cites this paper
• [Calcium pyrophosphate deposition disease].

  2011cites this paper
• Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease.

  2011cites this paper
• Применение мелоксикама (Амелотекс®) у больных пирофосфатной артропатией

  2011cites this paper
• Therapeutic consequences of crystals in the synovial fluid: a review for clinicians.

  2011cites this paper
• Tratamiento de la enfermedad por cristales de pirofosfato cálcico

  2010cites this paper
• Clinical presentation and diagnosis of calcium deposition diseases

  2010cites this paper
• Chondrocalcinose et arthropathies a dépôts de cristaux de pyrophosphate de calcium: actualité 2010.

  2010cites this paper
• The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review.

  2010cites this paper
• L'anakinra est une alternative possible dans le traitement et la prévention des crises de pseudogoutte au stade terminal d'une insuffisance rénale

  2009cites this paper
• Calcium Crystals and Arthritis: What Is New Under Polarizing Light?

  2009cites this paper
• Calcium Pyrophosphate Dihydrate (CPPD) Crystal Deposition Disease

  2009cites this paper
• Anakinra is a possible alternative in the treatment and prevention of acute attacks of pseudogout in end-stage renal failure.

  2009cites this paper
• Diseases Associated with Articular Deposition of Calcium Pyrophosphate Dihydrate and Basic Calcium Phosphate Crystals

  2009cites this paper
• All About Gout and Pseudogout: Meeting a Growing Challenge

  2009cites this paper
• [Diagnosis of microcrystalline arthropathy].

  2008cites this paper
• [Familiar chondrocalcinosis: a story for two brothers].

  2008cites this paper
• Successful treatment of resistant pseudogout with anakinra.

  2008cites this paper
• Treating difficult crystal pyrophosphate dihydrate deposition disease

  2008cites this paper
• Chondrokalzinose und Pseudogicht – aktueller denn je

  2008cites this paper
• Premature enthusiasm for the use of methotrexate for refractory chondrocalcinosis: comment on the article by Chollet-Janin et al.

  2008cites this paper
• Suppressive treatment of calcium pyrophosphate deposition disease.

  2007cites this paper
• Diagnose und Therapie der Kalziumpyrophosphatkristall-induzierten Arthropathie

  2007cites this paper
• Lu.141Méthotrexate et les chondrocalcinoses réfractaires : à propos de trois cas

  2007cites this paper
• [Diagnosis and treatment of calcium pyrophosphate crystal-induced arthropathy].

  2007cites this paper
• Recent developments in crystal-induced inflammation pathogenesis and management

  2007cites this paper
• Calcium pyrophosphate crystal deposition disease: diagnosis and treatment

  year unknowncites this paper
• Open Access Rheumatology: Research and Reviews Dovepress Calcium Pyrophosphate Crystal Deposition Disease: Diagnosis and Treatment

  year unknowncites this paper